OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · Real-Time Price · USD
1.520
-0.050 (-3.18%)
At close: Aug 11, 2026, 4:00 PM EDT
1.600
+0.080 (5.26%)
After-hours: Aug 11, 2026, 4:22 PM EDT
OKYO Pharma Market Cap
OKYO Pharma has a market cap or net worth of $79.77 million as of August 11, 2026. Its market cap has decreased by -35.14% in one year.
Market Cap
79.77M
Enterprise Value
59.17M
1-Year Change
-35.14%
Ranking
Category
Stock Price
$1.52
ChartMarket Cap Chart
Since the IPO on May 17, 2022, OKYO Pharma's market cap has decreased from $86.61M to $79.77M, a decrease of -7.90%. That is a compound annual growth rate of -1.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 79.77M | 2.46% |
| Dec 31, 2025 | 77.85M | 100.10% |
| Dec 31, 2024 | 38.91M | -33.86% |
| Dec 29, 2023 | 58.83M | 38.58% |
| Dec 20, 2022 | 42.45M | -50.99% |
| May 17, 2022 | 86.61M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rallybio | 88.03M |
| Verrica Pharmaceuticals | 87.96M |
| Adicet Bio | 87.30M |
| Gossamer Bio | 86.09M |
| MAIA Biotechnology | 85.73M |
| NeurAxis | 85.08M |
| Alterity Therapeutics | 82.21M |
| Inovio Pharmaceuticals | 80.74M |